Baxter seeks to raise $600 million
Baxter International Inc., the maker of treatments for blood disorders, plans to sell $600 million of notes in two equal parts, according to a person familiar with the offering.
The Deerfield-based company will issue $300 million of debt due in 2013 that may pay 50 basis points more than similar-maturity Treasuries and $300 million of bonds due in 2020 that may pay 70 basis points over the benchmarks, said the person, who declined to be identified because terms aren't set. A basis point is 0.01 percentage point.
The notes may be sold as soon as today, the person said.
Article Comments
Guidelines: Keep it civil and on topic; no profanity, vulgarity, slurs or personal attacks. People who harass others or joke about tragedies will be blocked.
If a comment violates these standards or our terms of service, click the "flag" link in the lower-right corner of the comment box. To find our more, read our FAQ.